| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | platelet-derived growth factor binding | 1.12e-07 | 12 | 17 | 3 | GO:0048407 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 7.61e-06 | 46 | 17 | 3 | GO:0030020 | |
| GeneOntologyMolecularFunction | growth factor binding | 2.93e-04 | 156 | 17 | 3 | GO:0019838 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 5.07e-04 | 188 | 17 | 3 | GO:0005201 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 8.49e-04 | 51 | 17 | 2 | GO:0043394 | |
| GeneOntologyBiologicalProcess | collagen fibril organization | 3.15e-05 | 76 | 17 | 3 | GO:0030199 | |
| GeneOntologyBiologicalProcess | dicarboxylic acid biosynthetic process | 7.62e-05 | 16 | 17 | 2 | GO:0043650 | |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 9.78e-08 | 12 | 17 | 3 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 9.78e-08 | 12 | 17 | 3 | GO:0098643 | |
| GeneOntologyCellularComponent | complex of collagen trimers | 5.89e-07 | 21 | 17 | 3 | GO:0098644 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 5.19e-06 | 332 | 17 | 5 | GO:0005788 | |
| GeneOntologyCellularComponent | collagen type XI trimer | 6.22e-06 | 5 | 17 | 2 | GO:0005592 | |
| GeneOntologyCellularComponent | collagen trimer | 4.70e-05 | 88 | 17 | 3 | GO:0005581 | |
| GeneOntologyCellularComponent | supramolecular fiber | 1.98e-03 | 1179 | 17 | 5 | GO:0099512 | |
| GeneOntologyCellularComponent | supramolecular polymer | 2.04e-03 | 1187 | 17 | 5 | GO:0099081 | |
| GeneOntologyCellularComponent | basement membrane | 4.34e-03 | 122 | 17 | 2 | GO:0005604 | |
| GeneOntologyCellularComponent | presynaptic active zone | 5.75e-03 | 141 | 17 | 2 | GO:0048786 | |
| HumanPheno | Subcutaneous spheroids | 4.85e-06 | 3 | 7 | 2 | HP:0025014 | |
| HumanPheno | Joint subluxation | 7.03e-06 | 31 | 7 | 3 | HP:0032153 | |
| HumanPheno | Cervical insufficiency | 9.70e-06 | 4 | 7 | 2 | HP:0030009 | |
| HumanPheno | Piezogenic pedal papules | 9.70e-06 | 4 | 7 | 2 | HP:0025509 | |
| HumanPheno | Incisional hernia | 9.70e-06 | 4 | 7 | 2 | HP:0004872 | |
| HumanPheno | Acrocyanosis | 1.11e-05 | 36 | 7 | 3 | HP:0001063 | |
| HumanPheno | Peripheral cyanosis | 1.31e-05 | 38 | 7 | 3 | HP:0034033 | |
| HumanPheno | Generalized joint hypermobility | 2.68e-05 | 48 | 7 | 3 | HP:0002761 | |
| HumanPheno | Pulp calcification | 3.39e-05 | 7 | 7 | 2 | HP:0003771 | |
| HumanPheno | Phalangeal dislocation | 3.39e-05 | 7 | 7 | 2 | HP:0006243 | |
| HumanPheno | Molluscoid pseudotumors | 3.39e-05 | 7 | 7 | 2 | HP:0000993 | |
| HumanPheno | Uterine prolapse | 3.39e-05 | 7 | 7 | 2 | HP:0000139 | |
| HumanPheno | Joint laxity | 4.04e-05 | 55 | 7 | 3 | HP:0001388 | |
| HumanPheno | Edema | 4.05e-05 | 699 | 7 | 6 | HP:0000969 | |
| HumanPheno | Limb pain | 4.51e-05 | 57 | 7 | 3 | HP:0009763 | |
| HumanPheno | Genital hernia | 4.52e-05 | 8 | 7 | 2 | HP:0100823 | |
| HumanPheno | Arterial rupture | 4.52e-05 | 8 | 7 | 2 | HP:0025019 | |
| HumanPheno | Blepharochalasis | 4.52e-05 | 8 | 7 | 2 | HP:0010749 | |
| HumanPheno | Osteoarthritis | 6.69e-05 | 65 | 7 | 3 | HP:0002758 | |
| HumanPheno | Cigarette-paper scars | 7.25e-05 | 10 | 7 | 2 | HP:0001073 | |
| HumanPheno | Abnormality of fluid regulation | 8.26e-05 | 789 | 7 | 6 | HP:0011032 | |
| HumanPheno | Arterial dissection | 1.06e-04 | 12 | 7 | 2 | HP:0005294 | |
| HumanPheno | Dermatochalasis | 1.06e-04 | 12 | 7 | 2 | HP:0010750 | |
| HumanPheno | Arteriovenous fistula | 1.06e-04 | 12 | 7 | 2 | HP:0004947 | |
| HumanPheno | Abnormal uterine cervix morphology | 1.25e-04 | 13 | 7 | 2 | HP:0012888 | |
| HumanPheno | Tricuspid valve prolapse | 1.46e-04 | 14 | 7 | 2 | HP:0001704 | |
| HumanPheno | Neonatal short-limb short stature | 1.46e-04 | 14 | 7 | 2 | HP:0008921 | |
| HumanPheno | Soft, doughy skin | 1.46e-04 | 14 | 7 | 2 | HP:0001027 | |
| HumanPheno | Abnormal knee physiology | 1.60e-04 | 87 | 7 | 3 | HP:0034670 | |
| HumanPheno | Arthritis | 1.79e-04 | 251 | 7 | 4 | HP:0001369 | |
| HumanPheno | Gastroesophageal reflux | 1.87e-04 | 517 | 7 | 5 | HP:0002020 | |
| HumanPheno | Premature rupture of membranes | 2.18e-04 | 17 | 7 | 2 | HP:0001788 | |
| HumanPheno | Short limb dwarfism | 2.74e-04 | 19 | 7 | 2 | HP:0003505 | |
| HumanPheno | Abnormality of the temporomandibular joint | 2.74e-04 | 19 | 7 | 2 | HP:0010754 | |
| HumanPheno | Shoulder dislocation | 3.04e-04 | 20 | 7 | 2 | HP:0003834 | |
| HumanPheno | Generalized osteoporosis | 3.04e-04 | 20 | 7 | 2 | HP:0040160 | |
| HumanPheno | Abnormal patella morphology | 3.13e-04 | 109 | 7 | 3 | HP:0003045 | |
| HumanPheno | Hypotension | 3.13e-04 | 109 | 7 | 3 | HP:0002615 | |
| HumanPheno | Dwarfism | 3.36e-04 | 21 | 7 | 2 | HP:0001516 | |
| HumanPheno | Cyanosis | 3.86e-04 | 117 | 7 | 3 | HP:0000961 | |
| HumanPheno | Mitral valve prolapse | 4.48e-04 | 123 | 7 | 3 | HP:0001634 | |
| HumanPheno | Biconcave vertebral bodies | 4.78e-04 | 25 | 7 | 2 | HP:0004586 | |
| HumanPheno | Abnormal 3rd finger morphology | 5.18e-04 | 26 | 7 | 2 | HP:0004150 | |
| HumanPheno | Abnormal autonomic nervous system physiology | 5.27e-04 | 130 | 7 | 3 | HP:0012332 | |
| HumanPheno | Pulmonic regurgitation | 5.59e-04 | 27 | 7 | 2 | HP:0010444 | |
| HumanPheno | Dermal translucency | 5.59e-04 | 27 | 7 | 2 | HP:0010648 | |
| HumanPheno | Avascular necrosis of the capital femoral epiphysis | 6.91e-04 | 30 | 7 | 2 | HP:0005743 | |
| HumanPheno | Abnormal mitral valve morphology | 7.42e-04 | 146 | 7 | 3 | HP:0031477 | |
| HumanPheno | Pes planus | 7.63e-04 | 365 | 7 | 4 | HP:0001763 | |
| HumanPheno | Abnormality of prenatal development or birth | 7.75e-04 | 1159 | 7 | 6 | HP:0001197 | |
| HumanPheno | Bell-shaped thorax | 8.38e-04 | 33 | 7 | 2 | HP:0001591 | |
| HumanPheno | Limitation of neck motion | 9.97e-04 | 36 | 7 | 2 | HP:0005986 | |
| HumanPheno | Abnormal neck physiology | 9.97e-04 | 36 | 7 | 2 | HP:0025669 | |
| HumanPheno | Bladder diverticulum | 9.97e-04 | 36 | 7 | 2 | HP:0000015 | |
| HumanPheno | Abnormal stomach morphology | 1.05e-03 | 742 | 7 | 5 | HP:0002577 | |
| HumanPheno | Atrophic scars | 1.05e-03 | 37 | 7 | 2 | HP:0001075 | |
| HumanPheno | Fragile skin | 1.05e-03 | 37 | 7 | 2 | HP:0001030 | |
| HumanPheno | Hiatus hernia | 1.11e-03 | 38 | 7 | 2 | HP:0002036 | |
| HumanPheno | Striae distensae | 1.11e-03 | 38 | 7 | 2 | HP:0001065 | |
| HumanPheno | Palpebral edema | 1.17e-03 | 39 | 7 | 2 | HP:0100540 | |
| HumanPheno | Decreased skull ossification | 1.17e-03 | 39 | 7 | 2 | HP:0004331 | |
| HumanPheno | Tibial bowing | 1.29e-03 | 41 | 7 | 2 | HP:0002982 | |
| HumanPheno | Premature birth | 1.30e-03 | 177 | 7 | 3 | HP:0001622 | |
| HumanPheno | Orthostatic hypotension | 1.36e-03 | 42 | 7 | 2 | HP:0001278 | |
| HumanPheno | Lens dislocation | 1.42e-03 | 43 | 7 | 2 | HP:0000665 | |
| HumanPheno | Juvenile aseptic necrosis | 1.42e-03 | 43 | 7 | 2 | HP:0100323 | |
| HumanPheno | Abnormal 2nd finger morphology | 1.42e-03 | 43 | 7 | 2 | HP:0004100 | |
| HumanPheno | Ectopia lentis | 1.42e-03 | 43 | 7 | 2 | HP:0001083 | |
| HumanPheno | Soft skin | 1.49e-03 | 44 | 7 | 2 | HP:0000977 | |
| HumanPheno | Prolonged bleeding time | 1.92e-03 | 50 | 7 | 2 | HP:0003010 | |
| MousePheno | abnormal respiratory system physiology | 4.54e-05 | 897 | 12 | 6 | MP:0002133 | |
| MousePheno | pulmonary alveolar hemorrhage | 8.05e-05 | 16 | 12 | 2 | MP:0010909 | |
| MousePheno | abnormal joint mobility | 9.12e-05 | 17 | 12 | 2 | MP:0008069 | |
| MousePheno | small vertebral body | 1.15e-04 | 19 | 12 | 2 | MP:0004670 | |
| MousePheno | decreased skin tensile strength | 2.17e-04 | 26 | 12 | 2 | MP:0003089 | |
| MousePheno | abnormal stationary movement | 2.34e-04 | 147 | 12 | 3 | MP:0001388 | |
| MousePheno | abnormal cutaneous collagen fibril morphology | 2.34e-04 | 27 | 12 | 2 | MP:0008438 | |
| MousePheno | abnormal endoplasmic reticulum morphology | 2.52e-04 | 28 | 12 | 2 | MP:0009378 | |
| MousePheno | abnormal skin tensile strength | 3.30e-04 | 32 | 12 | 2 | MP:0005275 | |
| MousePheno | abnormal craniofacial development | 3.43e-04 | 425 | 12 | 4 | MP:0003935 | |
| MousePheno | abnormal chest morphology | 4.92e-04 | 39 | 12 | 2 | MP:0004134 | |
| MousePheno | abnormal face size | 5.71e-04 | 42 | 12 | 2 | MP:0030063 | |
| MousePheno | respiratory distress | 6.11e-04 | 204 | 12 | 3 | MP:0001954 | |
| MousePheno | perinatal lethality, incomplete penetrance | 6.51e-04 | 503 | 12 | 4 | MP:0011090 | |
| MousePheno | stereotypic behavior | 7.03e-04 | 214 | 12 | 3 | MP:0001408 | |
| MousePheno | abnormal fibula morphology | 8.41e-04 | 51 | 12 | 2 | MP:0002187 | |
| MousePheno | lung hemorrhage | 8.75e-04 | 52 | 12 | 2 | MP:0001182 | |
| MousePheno | decreased thermal nociceptive threshold | 9.43e-04 | 54 | 12 | 2 | MP:0003998 | |
| MousePheno | decreased trabecular bone volume | 1.16e-03 | 60 | 12 | 2 | MP:0010879 | |
| MousePheno | abnormal respiration | 1.25e-03 | 598 | 12 | 4 | MP:0001943 | |
| MousePheno | abnormal vertebral body morphology | 1.41e-03 | 66 | 12 | 2 | MP:0000141 | |
| MousePheno | abnormal pulmonary circulation | 1.53e-03 | 69 | 12 | 2 | MP:0002295 | |
| MousePheno | decreased bone trabecula number | 1.58e-03 | 70 | 12 | 2 | MP:0010869 | |
| MousePheno | abnormal skin physiology | 1.66e-03 | 288 | 12 | 3 | MP:0005501 | |
| MousePheno | perinatal lethality | 1.67e-03 | 1130 | 12 | 5 | MP:0002081 | |
| MousePheno | neonatal lethality, incomplete penetrance | 1.83e-03 | 298 | 12 | 3 | MP:0011088 | |
| MousePheno | hemorrhage | 1.84e-03 | 664 | 12 | 4 | MP:0001914 | |
| MousePheno | abnormal breathing pattern | 1.92e-03 | 303 | 12 | 3 | MP:0001951 | |
| MousePheno | hyperalgesia | 1.96e-03 | 78 | 12 | 2 | MP:0005407 | |
| MousePheno | embryonic lethality during organogenesis, complete penetrance | 2.23e-03 | 700 | 12 | 4 | MP:0011098 | |
| MousePheno | abnormal ulna morphology | 2.26e-03 | 84 | 12 | 2 | MP:0005108 | |
| MousePheno | decreased percent body fat/body weight | 2.26e-03 | 84 | 12 | 2 | MP:0005459 | |
| MousePheno | decreased bone marrow cell number | 2.37e-03 | 86 | 12 | 2 | MP:0000333 | |
| MousePheno | abnormal pelvic girdle bone morphology | 2.43e-03 | 87 | 12 | 2 | MP:0004509 | |
| MousePheno | abnormal forelimb stylopod morphology | 2.71e-03 | 92 | 12 | 2 | MP:0003854 | |
| MousePheno | abnormal humerus morphology | 2.71e-03 | 92 | 12 | 2 | MP:0005296 | |
| MousePheno | weakness | 3.01e-03 | 97 | 12 | 2 | MP:0000746 | |
| MousePheno | decreased amino acid level | 3.01e-03 | 97 | 12 | 2 | MP:0014528 | |
| MousePheno | microcephaly | 3.01e-03 | 97 | 12 | 2 | MP:0000433 | |
| MousePheno | decreased bone volume | 3.19e-03 | 100 | 12 | 2 | MP:0010876 | |
| MousePheno | abnormal forelimb zeugopod morphology | 3.32e-03 | 102 | 12 | 2 | MP:0003855 | |
| MousePheno | abnormal head movements | 3.38e-03 | 103 | 12 | 2 | MP:0000436 | |
| MousePheno | neonatal lethality | 3.62e-03 | 799 | 12 | 4 | MP:0002058 | |
| MousePheno | decreased litter size | 3.65e-03 | 380 | 12 | 3 | MP:0001935 | |
| MousePheno | abnormal dermal layer morphology | 3.71e-03 | 108 | 12 | 2 | MP:0001243 | |
| MousePheno | internal hemorrhage | 3.85e-03 | 387 | 12 | 3 | MP:0001634 | |
| MousePheno | short limbs | 3.92e-03 | 111 | 12 | 2 | MP:0000547 | |
| MousePheno | abnormal trabecular bone volume | 4.05e-03 | 113 | 12 | 2 | MP:0010877 | |
| MousePheno | abnormal respiratory function | 4.19e-03 | 399 | 12 | 3 | MP:0002327 | |
| MousePheno | abnormal litter size | 4.19e-03 | 399 | 12 | 3 | MP:0001933 | |
| MousePheno | abnormal head shape | 4.20e-03 | 115 | 12 | 2 | MP:0011495 | |
| MousePheno | circling | 4.34e-03 | 117 | 12 | 2 | MP:0001394 | |
| MousePheno | abnormal blood circulation | 4.44e-03 | 845 | 12 | 4 | MP:0002128 | |
| Domain | Fib_collagen_C | 1.03e-07 | 11 | 17 | 3 | IPR000885 | |
| Domain | NC1_FIB | 1.03e-07 | 11 | 17 | 3 | PS51461 | |
| Domain | Fib_collagen_C | 1.03e-07 | 11 | 17 | 3 | PD002078 | |
| Domain | COLFI | 1.03e-07 | 11 | 17 | 3 | SM00038 | |
| Domain | COLFI | 1.03e-07 | 11 | 17 | 3 | PF01410 | |
| Domain | CENP-B_N | 3.49e-05 | 10 | 17 | 2 | PF04218 | |
| Domain | DDE_1 | 5.12e-05 | 12 | 17 | 2 | PF03184 | |
| Domain | HTH_PSQ | 5.12e-05 | 12 | 17 | 2 | PS50960 | |
| Domain | CENPB | 5.12e-05 | 12 | 17 | 2 | SM00674 | |
| Domain | HTH_Psq | 5.12e-05 | 12 | 17 | 2 | IPR007889 | |
| Domain | DDE_SF_endonuclease_dom | 5.12e-05 | 12 | 17 | 2 | IPR004875 | |
| Domain | Collagen | 5.91e-05 | 85 | 17 | 3 | PF01391 | |
| Domain | Collagen | 5.91e-05 | 85 | 17 | 3 | IPR008160 | |
| Domain | HTH_Tnp_Tc5 | 6.05e-05 | 13 | 17 | 2 | PF03221 | |
| Domain | HTH_CenpB_DNA-bd_dom | 6.05e-05 | 13 | 17 | 2 | IPR006600 | |
| Domain | HTH_CENPB | 6.05e-05 | 13 | 17 | 2 | PS51253 | |
| Domain | VWC | 2.91e-04 | 28 | 17 | 2 | PF00093 | |
| Domain | VWFC_1 | 4.82e-04 | 36 | 17 | 2 | PS01208 | |
| Domain | VWC | 5.38e-04 | 38 | 17 | 2 | SM00214 | |
| Domain | VWFC_2 | 5.38e-04 | 38 | 17 | 2 | PS50184 | |
| Domain | VWF_dom | 6.57e-04 | 42 | 17 | 2 | IPR001007 | |
| Domain | - | 3.96e-03 | 746 | 17 | 4 | 3.40.50.300 | |
| Domain | P-loop_NTPase | 6.25e-03 | 848 | 17 | 4 | IPR027417 | |
| Domain | - | 1.01e-02 | 169 | 17 | 2 | 3.40.50.720 | |
| Domain | NAD(P)-bd_dom | 1.06e-02 | 173 | 17 | 2 | IPR016040 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 7.49e-07 | 19 | 14 | 3 | MM15512 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 3.12e-06 | 30 | 14 | 3 | M27772 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 3.12e-06 | 30 | 14 | 3 | MM15517 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 3.80e-06 | 32 | 14 | 3 | MM14924 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 8.13e-06 | 41 | 14 | 3 | MM15538 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 8.13e-06 | 41 | 14 | 3 | M27778 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 1.01e-05 | 44 | 14 | 3 | M27812 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 1.15e-05 | 46 | 14 | 3 | M198 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.23e-05 | 47 | 14 | 3 | MM14925 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 1.49e-05 | 50 | 14 | 3 | MM14796 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.77e-05 | 53 | 14 | 3 | MM14566 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 2.45e-05 | 59 | 14 | 3 | M27218 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 2.71e-05 | 61 | 14 | 3 | M27103 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 2.71e-05 | 61 | 14 | 3 | MM14637 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 3.13e-05 | 64 | 14 | 3 | M26953 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 3.44e-05 | 66 | 14 | 3 | M18 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 3.60e-05 | 67 | 14 | 3 | M26999 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 3.60e-05 | 67 | 14 | 3 | MM15345 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 4.85e-05 | 74 | 14 | 3 | M160 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 5.25e-05 | 76 | 14 | 3 | MM14573 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 5.25e-05 | 76 | 14 | 3 | M27219 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 5.25e-05 | 76 | 14 | 3 | MM14867 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 5.90e-05 | 79 | 14 | 3 | M27643 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 7.09e-05 | 84 | 14 | 3 | M7098 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 7.34e-05 | 85 | 14 | 3 | M16441 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 8.71e-05 | 90 | 14 | 3 | M631 | |
| Pathway | WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS | 1.39e-04 | 18 | 14 | 2 | M39421 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.72e-04 | 20 | 14 | 2 | MM15061 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.76e-04 | 114 | 14 | 3 | MM14571 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 3.17e-04 | 27 | 14 | 2 | M27217 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 3.22e-04 | 140 | 14 | 3 | M587 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 6.31e-04 | 38 | 14 | 2 | MM14969 | |
| Pathway | WP_FOCAL_ADHESION | 7.51e-04 | 187 | 14 | 3 | MM15913 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 7.71e-04 | 42 | 14 | 2 | M7169 | |
| Pathway | KEGG_FOCAL_ADHESION | 8.99e-04 | 199 | 14 | 3 | M7253 | |
| Pathway | WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY | 1.09e-03 | 50 | 14 | 2 | M48087 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 1.42e-03 | 57 | 14 | 2 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 1.47e-03 | 58 | 14 | 2 | M2049 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.73e-03 | 63 | 14 | 2 | M11187 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.90e-03 | 258 | 14 | 3 | MM14572 | |
| Pathway | WP_UROTENSINIIMEDIATED_SIGNALING | 2.07e-03 | 69 | 14 | 2 | M48052 | |
| Pathway | WP_DRAVET_SYNDROME_SCN1AA1783V_POINT_MUTATION_MODEL | 2.31e-03 | 73 | 14 | 2 | MM16641 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.92e-03 | 300 | 14 | 3 | M610 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 2.97e-03 | 302 | 14 | 3 | M39719 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 3.69e-03 | 326 | 14 | 3 | MM15917 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | 5.15e-03 | 367 | 14 | 3 | M48346 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 7.38e-03 | 418 | 14 | 3 | MM15587 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 7.68e-03 | 135 | 14 | 2 | MM14781 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 1.43e-02 | 532 | 14 | 3 | M27870 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 1.48e-02 | 190 | 14 | 2 | M8240 | |
| Pathway | WP_FOCAL_ADHESION | 1.61e-02 | 199 | 14 | 2 | M39402 | |
| Pubmed | 9.70e-11 | 3 | 17 | 3 | 17024418 | ||
| Pubmed | 1.94e-09 | 6 | 17 | 3 | 21467034 | ||
| Pubmed | Developmental pattern of expression of the mouse alpha 1 (XI) collagen gene (Col11a1). | 1.94e-09 | 6 | 17 | 3 | 8563024 | |
| Pubmed | Interaction of human thrombospondin with types I-V collagen: direct binding and electron microscopy. | 1.94e-09 | 6 | 17 | 3 | 3571333 | |
| Pubmed | The pro-alpha2(XI) collagen gene is expressed in odontoblasts. | 5.42e-09 | 8 | 17 | 3 | 20059976 | |
| Pubmed | 8.13e-09 | 9 | 17 | 3 | 8900172 | ||
| Pubmed | 1.16e-08 | 10 | 17 | 3 | 2446864 | ||
| Pubmed | 1.60e-08 | 11 | 17 | 3 | 2745554 | ||
| Pubmed | Maturational disturbance of chondrocytes in Cbfa1-deficient mice. | 6.57e-08 | 17 | 17 | 3 | 10213384 | |
| Pubmed | 1.95e-07 | 24 | 17 | 3 | 25344368 | ||
| Pubmed | 2.22e-07 | 25 | 17 | 3 | 19180518 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 15095409 | ||
| Pubmed | Expression of the mouse alpha 1(II) collagen gene is not restricted to cartilage during development. | 2.25e-07 | 2 | 17 | 2 | 1879363 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 33409715 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 34356072 | ||
| Pubmed | Type V collagen controls the initiation of collagen fibril assembly. | 2.25e-07 | 2 | 17 | 2 | 15383546 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 19387081 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 6320112 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 8204907 | ||
| Pubmed | Increased type I and V collagen expression in uterine leiomyomas during the menstrual cycle. | 2.25e-07 | 2 | 17 | 2 | 21215393 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 31239369 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 38102224 | ||
| Pubmed | CbpA: a novel surface exposed adhesin of Clostridium difficile targeting human collagen. | 2.25e-07 | 2 | 17 | 2 | 23517059 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 23546968 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 28863946 | ||
| Pubmed | Distribution of collagen types I, III, and V in pregnant mouse endometrium. | 6.74e-07 | 3 | 17 | 2 | 17453912 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 28302318 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 16001263 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 12200454 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 20301422 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 15908193 | ||
| Pubmed | Developmental expression analysis of murine autotaxin (ATX). | 6.74e-07 | 3 | 17 | 2 | 10473125 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 18353721 | ||
| Pubmed | Distributions of types I, II and III collagen by region in the human supraspinatus tendon. | 6.74e-07 | 3 | 17 | 2 | 24088220 | |
| Pubmed | Mutations in collagen genes: causes of rare and some common diseases in humans. | 6.74e-07 | 3 | 17 | 2 | 2010058 | |
| Pubmed | 1.27e-06 | 44 | 17 | 3 | 21308778 | ||
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 29068597 | ||
| Pubmed | Collagen XI chain misassembly in cartilage of the chondrodysplasia (cho) mouse. | 1.35e-06 | 4 | 17 | 2 | 17683922 | |
| Pubmed | Cell and matrix response of temporomandibular cartilage to mechanical loading. | 1.35e-06 | 4 | 17 | 2 | 26362410 | |
| Pubmed | Immunohistochemical characteristics of developing mandibular angle in fetal mice. | 1.35e-06 | 4 | 17 | 2 | 16356873 | |
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 9880238 | ||
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 10633870 | ||
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 23624467 | ||
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 25987251 | ||
| Pubmed | Specific hybridization probes for mouse type I, II, III and IX collagen mRNAs. | 1.35e-06 | 4 | 17 | 2 | 2054384 | |
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 16537906 | ||
| Pubmed | ADAMTS3 activity is mandatory for embryonic lymphangiogenesis and regulates placental angiogenesis. | 1.36e-06 | 45 | 17 | 3 | 26446156 | |
| Pubmed | 1.87e-06 | 50 | 17 | 3 | 23658023 | ||
| Pubmed | Myh10 deficiency leads to defective extracellular matrix remodeling and pulmonary disease. | 2.11e-06 | 52 | 17 | 3 | 30389913 | |
| Pubmed | 2.25e-06 | 5 | 17 | 2 | 38899779 | ||
| Pubmed | The matrix Gla protein gene is a marker of the chondrogenesis cell lineage during mouse development. | 2.25e-06 | 5 | 17 | 2 | 7754814 | |
| Pubmed | Optimizing a 3D model system for molecular manipulation of tenogenesis. | 2.25e-06 | 5 | 17 | 2 | 28937836 | |
| Pubmed | 2.25e-06 | 5 | 17 | 2 | 17099713 | ||
| Pubmed | 2.25e-06 | 5 | 17 | 2 | 19235716 | ||
| Pubmed | Cthrc1 is a positive regulator of osteoblastic bone formation. | 2.25e-06 | 5 | 17 | 2 | 18779865 | |
| Pubmed | 2.25e-06 | 5 | 17 | 2 | 11973338 | ||
| Pubmed | Cooperation of Hoxa5 and Pax1 genes during formation of the pectoral girdle. | 2.25e-06 | 5 | 17 | 2 | 11900462 | |
| Pubmed | Collagen and tenascin-C expression along the migration pathway of mouse primordial germ cells. | 2.25e-06 | 5 | 17 | 2 | 14758483 | |
| Pubmed | 2.25e-06 | 5 | 17 | 2 | 27467521 | ||
| Pubmed | Modulation of let-7 miRNAs controls the differentiation of effector CD8 T cells. | 2.25e-06 | 5 | 17 | 2 | 28737488 | |
| Pubmed | 2.25e-06 | 5 | 17 | 2 | 25521223 | ||
| Pubmed | 3.37e-06 | 6 | 17 | 2 | 31874220 | ||
| Pubmed | ColVa1 and ColXIa1 are required for myocardial morphogenesis and heart valve development. | 3.37e-06 | 6 | 17 | 2 | 17029294 | |
| Pubmed | 3.37e-06 | 6 | 17 | 2 | 15042706 | ||
| Pubmed | Development and regeneration of the neonatal digit tip in mice. | 3.37e-06 | 6 | 17 | 2 | 18234177 | |
| Pubmed | Retarded skeletal development in transgenic mice with a type II collagen mutation. | 3.37e-06 | 6 | 17 | 2 | 8952549 | |
| Pubmed | Mouse clavicular development: analysis of wild-type and cleidocranial dysplasia mutant mice. | 3.37e-06 | 6 | 17 | 2 | 9286593 | |
| Pubmed | 3.37e-06 | 6 | 17 | 2 | 20603131 | ||
| Pubmed | 3.37e-06 | 6 | 17 | 2 | 9755172 | ||
| Pubmed | 3.37e-06 | 6 | 17 | 2 | 9101290 | ||
| Pubmed | 3.37e-06 | 6 | 17 | 2 | 17876790 | ||
| Pubmed | 3.37e-06 | 6 | 17 | 2 | 7813775 | ||
| Pubmed | 3.37e-06 | 6 | 17 | 2 | 16556917 | ||
| Pubmed | Antxr1, Which is a Target of Runx2, Regulates Chondrocyte Proliferation and Apoptosis. | 3.37e-06 | 6 | 17 | 2 | 32244499 | |
| Pubmed | The molecular chaperone Hsp47 is essential for cartilage and endochondral bone formation. | 3.37e-06 | 6 | 17 | 2 | 22492985 | |
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 3.60e-06 | 62 | 17 | 3 | 28344315 | |
| Pubmed | Abnormalities in cartilage and bone development in the Apert syndrome FGFR2(+/S252W) mouse. | 4.72e-06 | 7 | 17 | 2 | 15975938 | |
| Pubmed | Core-binding factor beta interacts with Runx2 and is required for skeletal development. | 4.72e-06 | 7 | 17 | 2 | 12434152 | |
| Pubmed | 4.72e-06 | 7 | 17 | 2 | 23762363 | ||
| Pubmed | Snail1 is a transcriptional effector of FGFR3 signaling during chondrogenesis and achondroplasias. | 4.72e-06 | 7 | 17 | 2 | 18061568 | |
| Pubmed | Sox9 is required for determination of the chondrogenic cell lineage in the cranial neural crest. | 4.72e-06 | 7 | 17 | 2 | 12878728 | |
| Pubmed | 4.72e-06 | 7 | 17 | 2 | 9426396 | ||
| Pubmed | 4.72e-06 | 7 | 17 | 2 | 18759297 | ||
| Pubmed | 4.72e-06 | 7 | 17 | 2 | 10072783 | ||
| Pubmed | 4.72e-06 | 7 | 17 | 2 | 12847218 | ||
| Pubmed | 6.29e-06 | 8 | 17 | 2 | 15107406 | ||
| Pubmed | Early onset of Runx2 expression caused craniosynostosis, ectopic bone formation, and limb defects. | 6.29e-06 | 8 | 17 | 2 | 21807129 | |
| Pubmed | 6.29e-06 | 8 | 17 | 2 | 15039145 | ||
| Pubmed | 6.29e-06 | 8 | 17 | 2 | 27664939 | ||
| Pubmed | Filamin B mutations cause chondrocyte defects in skeletal development. | 6.29e-06 | 8 | 17 | 2 | 17510210 | |
| Pubmed | The involvement of cytokine-like 1 (Cytl1) in chondrogenesis and cartilage metabolism. | 6.29e-06 | 8 | 17 | 2 | 32736681 | |
| Pubmed | 6.29e-06 | 8 | 17 | 2 | 11847210 | ||
| Pubmed | Type XIII collagen strongly affects bone formation in transgenic mice. | 6.29e-06 | 8 | 17 | 2 | 16007336 | |
| Pubmed | 6.29e-06 | 8 | 17 | 2 | 20368361 | ||
| Pubmed | 6.29e-06 | 8 | 17 | 2 | 15872058 | ||
| Pubmed | 6.29e-06 | 8 | 17 | 2 | 26553654 | ||
| Pubmed | Lasp1 misexpression influences chondrocyte differentiation in the vertebral column. | 6.29e-06 | 8 | 17 | 2 | 19378260 | |
| Pubmed | In vivo evidence for a bridging role of a collagen V subtype at the epidermis-dermis interface. | 6.29e-06 | 8 | 17 | 2 | 22437311 | |
| Pubmed | 3D Mapping Reveals a Complex and Transient Interstitial Matrix During Murine Kidney Development. | 6.29e-06 | 8 | 17 | 2 | 33875569 | |
| Pubmed | 6.29e-06 | 8 | 17 | 2 | 23720048 | ||
| Interaction | MAG interactions | 1.80e-06 | 29 | 17 | 3 | int:MAG | |
| Interaction | PDGFA interactions | 2.44e-06 | 32 | 17 | 3 | int:PDGFA | |
| Interaction | THBS1 interactions | 3.36e-06 | 127 | 17 | 4 | int:THBS1 | |
| Interaction | TIGD2 interactions | 6.69e-06 | 5 | 17 | 2 | int:TIGD2 | |
| Interaction | C1QTNF1 interactions | 7.90e-06 | 47 | 17 | 3 | int:C1QTNF1 | |
| Interaction | LAIR2 interactions | 8.97e-06 | 49 | 17 | 3 | int:LAIR2 | |
| Interaction | C1QTNF2 interactions | 1.83e-05 | 62 | 17 | 3 | int:C1QTNF2 | |
| Interaction | JRKL interactions | 1.87e-05 | 8 | 17 | 2 | int:JRKL | |
| Interaction | SPARC interactions | 2.11e-05 | 65 | 17 | 3 | int:SPARC | |
| Interaction | MMP9 interactions | 2.31e-05 | 67 | 17 | 3 | int:MMP9 | |
| Interaction | MMP2 interactions | 5.06e-05 | 87 | 17 | 3 | int:MMP2 | |
| Interaction | PDGFB interactions | 5.23e-05 | 88 | 17 | 3 | int:PDGFB | |
| Interaction | FGF7 interactions | 7.98e-05 | 16 | 17 | 2 | int:FGF7 | |
| Interaction | BMP1 interactions | 1.05e-04 | 111 | 17 | 3 | int:BMP1 | |
| Interaction | TNFRSF10A interactions | 1.95e-04 | 137 | 17 | 3 | int:TNFRSF10A | |
| Interaction | TGFBI interactions | 1.99e-04 | 25 | 17 | 2 | int:TGFBI | |
| Interaction | BGN interactions | 2.87e-04 | 30 | 17 | 2 | int:BGN | |
| Interaction | PRELP interactions | 3.27e-04 | 32 | 17 | 2 | int:PRELP | |
| Interaction | VWF interactions | 3.27e-04 | 32 | 17 | 2 | int:VWF | |
| Interaction | RFK interactions | 3.48e-04 | 33 | 17 | 2 | int:RFK | |
| Interaction | C1QC interactions | 5.65e-04 | 42 | 17 | 2 | int:C1QC | |
| Interaction | COL8A2 interactions | 5.65e-04 | 42 | 17 | 2 | int:COL8A2 | |
| Interaction | KYAT3 interactions | 5.93e-04 | 43 | 17 | 2 | int:KYAT3 | |
| Interaction | DCN interactions | 5.93e-04 | 43 | 17 | 2 | int:DCN | |
| Interaction | GYG1 interactions | 7.08e-04 | 47 | 17 | 2 | int:GYG1 | |
| Interaction | KIAA1191 interactions | 8.01e-04 | 50 | 17 | 2 | int:KIAA1191 | |
| Interaction | PRF1 interactions | 8.33e-04 | 51 | 17 | 2 | int:PRF1 | |
| Interaction | BCL6 interactions | 8.75e-04 | 229 | 17 | 3 | int:BCL6 | |
| Interaction | PKD1 interactions | 9.00e-04 | 53 | 17 | 2 | int:PKD1 | |
| Interaction | HTRA1 interactions | 9.34e-04 | 54 | 17 | 2 | int:HTRA1 | |
| Interaction | PCSK6 interactions | 1.08e-03 | 58 | 17 | 2 | int:PCSK6 | |
| Interaction | COLGALT2 interactions | 1.43e-03 | 67 | 17 | 2 | int:COLGALT2 | |
| Interaction | TIMP2 interactions | 1.51e-03 | 277 | 17 | 3 | int:TIMP2 | |
| GeneFamily | Collagens | 4.33e-06 | 46 | 13 | 3 | 490 | |
| GeneFamily | Helix-turn-helix CENPB type domain containing | 3.71e-05 | 13 | 13 | 2 | 533 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 8.19e-07 | 29 | 17 | 3 | MM17055 | |
| Coexpression | NABA_COLLAGENS | 2.75e-06 | 43 | 17 | 3 | MM17060 | |
| Coexpression | NABA_COLLAGENS | 2.95e-06 | 44 | 17 | 3 | M3005 | |
| Coexpression | KANG_AR_TARGETS_UP | 5.35e-05 | 17 | 17 | 2 | M2223 | |
| Coexpression | KANG_AR_TARGETS_UP | 5.35e-05 | 17 | 17 | 2 | MM1297 | |
| Coexpression | DESCARTES_MAIN_FETAL_STROMAL_CELLS | 9.08e-05 | 22 | 17 | 2 | M40074 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.79e-07 | 195 | 17 | 4 | fee9d13f48149cd5f921cfe4b8b3053cf6a6dbd2 | |
| ToppCell | B_cell_maturation-CD34+_pro-B|World / Lineage and Cell class | 7.95e-07 | 196 | 17 | 4 | 4cb046883e56524963f6469ddb3b82c3c9853379 | |
| ToppCell | lymphoid-B_cell-pro-B|World / Lineage, cell class and subclass | 2.95e-05 | 161 | 17 | 3 | 23138e579f07d5a6f20d41457cb573b4ac95a4ef | |
| ToppCell | AT1-AT2_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 3.00e-05 | 162 | 17 | 3 | 57d627259d27f39885bf416d74bcb6656db6e27b | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-8|TCGA-Liver / Sample_Type by Project: Shred V9 | 3.53e-05 | 171 | 17 | 3 | c4a919fe3d56ae6df2fcab6686abacc10befc053 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-H-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.71e-05 | 174 | 17 | 3 | 2627c3983009839fedbc5e3f628739dc026447f4 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-H|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.71e-05 | 174 | 17 | 3 | 507a33e58f62e2b72f0bcc743e84dbd0bf705a15 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.71e-05 | 174 | 17 | 3 | 1779e67382cb2644534ffb5b9b8f28d32935f4ea | |
| ToppCell | B_cell_maturation-CD34+_pre-plamsa|World / Lineage and Cell class | 3.91e-05 | 177 | 17 | 3 | 3ff06100deee9bee852a52078666999a9f7beaf1 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.04e-05 | 179 | 17 | 3 | ff678e2f33c914e3dd0f338ada25f506c3e3c980 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 4.11e-05 | 180 | 17 | 3 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.18e-05 | 181 | 17 | 3 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.39e-05 | 184 | 17 | 3 | e33e2a887aafba7b6a31f00bb0dbe974b4359fd6 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-4|TCGA-Bladder / Sample_Type by Project: Shred V9 | 4.46e-05 | 185 | 17 | 3 | e1f3f0e974eb3fe1c05018beb9e124c7fb0cbe50 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.46e-05 | 185 | 17 | 3 | c85bba1210f1d389add3e40be9b96abac40cf8c1 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-05 | 185 | 17 | 3 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-05 | 185 | 17 | 3 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.53e-05 | 186 | 17 | 3 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-05 | 186 | 17 | 3 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 4.68e-05 | 188 | 17 | 3 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | 4.68e-05 | 188 | 17 | 3 | 7b1e3f8a941eaa68e89c562129a92314642eec66 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.75e-05 | 189 | 17 | 3 | eccf3d49354a67c94f1ed7c15a98a48a5e8e2ed0 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.75e-05 | 189 | 17 | 3 | 40764f461b8aa1d3a2c5a30590b7fb9307d47d09 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.83e-05 | 190 | 17 | 3 | f5fb989afabb49d64d91324570cd8c80a4b9e67d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.83e-05 | 190 | 17 | 3 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.83e-05 | 190 | 17 | 3 | 562ee3b025c29edf07b8b344323edb49d82f1c7e | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.90e-05 | 191 | 17 | 3 | 44b1f62fdee03b157fe545f2ae6ff84f8929a8ac | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.90e-05 | 191 | 17 | 3 | 5271198116343c07202649889057e5774d7fdde3 | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.90e-05 | 191 | 17 | 3 | 053b3664f509baa107feaf90730f80ebf9ac8f14 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.98e-05 | 192 | 17 | 3 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.06e-05 | 193 | 17 | 3 | 146e8c148478ab61b1c1dbaf1ee98a8cd4a0ff8a | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.06e-05 | 193 | 17 | 3 | dd4bac8a93a5b9dcf7301f1d7d6e3eb6670f5c68 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.06e-05 | 193 | 17 | 3 | 2ddf9b2770a0be9689e01d1a3d19e4a6d42c7a50 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.13e-05 | 194 | 17 | 3 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 5.13e-05 | 194 | 17 | 3 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.13e-05 | 194 | 17 | 3 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-bladder_mesenchymal_cell_(Scara5+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.21e-05 | 195 | 17 | 3 | d663d54a4bcc94e2c9b50ed931e2b2db4ca41373 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.29e-05 | 196 | 17 | 3 | cb61757646653f89faba503cb5d99e5dd5197b4c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.29e-05 | 196 | 17 | 3 | 44e2df1b61e3819eae7e482bef0a733afe852d67 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-05 | 197 | 17 | 3 | 036c4c9b3ae80e2dc21c24a84504d3da0541f945 | |
| ToppCell | droplet-Bladder-BLADDER|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-05 | 197 | 17 | 3 | 5ae84f796005fa7b75d10b6464770da6cd5c8f53 | |
| ToppCell | droplet-Bladder-BLADDER-1m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-05 | 197 | 17 | 3 | 1e24150c5146c93914aaaa981bd17589e8ed7cf9 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 5.37e-05 | 197 | 17 | 3 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.45e-05 | 198 | 17 | 3 | d3a475be01657a03fcbb0ee0a246b1e90deacaa4 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.45e-05 | 198 | 17 | 3 | 1f956e369e00d37835095a001db4b62a79014532 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.45e-05 | 198 | 17 | 3 | dc6fbad0ecdd057189f71afcdb6aca25207314a3 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.45e-05 | 198 | 17 | 3 | 1beed34f469aad07e8f674f0b668d6e1e916403c | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.45e-05 | 198 | 17 | 3 | 8f202ed4692ea2c139ff05d4805c704ee4be095c | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.45e-05 | 198 | 17 | 3 | b086af292a508a156266c2d899ba1caf820bf61c | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.45e-05 | 198 | 17 | 3 | 1b90d632e59c3c47b936e829cceeb0334f05f34f | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.45e-05 | 198 | 17 | 3 | 985022c1722ab7b67675ebe814022a439e715b5e | |
| ToppCell | B_cell_maturation-CD34+_pro-B|B_cell_maturation / Lineage and Cell class | 5.45e-05 | 198 | 17 | 3 | 5737606e5e3dc56f11fdf70166caf4ba4a81bc9d | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.45e-05 | 198 | 17 | 3 | 524305c5d7b1d53e86ec0af775efefa3e0955e47 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Proliferative_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.54e-05 | 199 | 17 | 3 | b65fbfed4a9938820cf900afd350b4ecb789b7b3 | |
| ToppCell | droplet-Heart-HEART-1m-Hematologic-erythrocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-04 | 75 | 17 | 2 | f1ad409d1b2c5f23bf2b22137e612d627c041b97 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal-Unfolded_protein_responsible_cell|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 6.64e-04 | 101 | 17 | 2 | ae650e96b93a0d2f0a19ffaf37f21f02fb20651d | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Dcn-Endothelial_Tip.Dcn.Nenf_(Nenf)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 8.44e-04 | 114 | 17 | 2 | 7be16e7f7b9c9dbd68933ace3b7f8f661bed41a7 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Dcn|Thalamus / BrainAtlas - Mouse McCarroll V32 | 8.44e-04 | 114 | 17 | 2 | f4bdfc47418d22a49e0c4a6c3bd0663e15fb53bb | |
| ToppCell | RA-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 8.59e-04 | 115 | 17 | 2 | 0a37816898eaa18ae49d4d936e1a760f089e0ceb | |
| ToppCell | Bronchial-10x5prime-Stromal-Schwann-Schwann_nonmyelinating|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.74e-04 | 116 | 17 | 2 | b0a3c109c5f20ab699e53bf8ab3903d102f5f315 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-regulatory_T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.35e-04 | 120 | 17 | 2 | 85048159084e15bc9c26021be30f5551858f3701 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.03e-03 | 126 | 17 | 2 | feedea978d76de326c14da5149e57d0d767271b9 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.03e-03 | 126 | 17 | 2 | 6311cc64320db7e24a09065ebdf054f5f551b182 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.06e-03 | 128 | 17 | 2 | 91072ca56bce2c552a95edd67e17f43d8cc1de95 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.16e-03 | 134 | 17 | 2 | d29ac8152dc581c0da2430d06cd259ac0eded808 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.16e-03 | 134 | 17 | 2 | 459c39df15d3cf9144ce7827e8d14830d31353bb | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Col3a1_(Mural.Rgs5Acta2.Col3a1)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.16e-03 | 134 | 17 | 2 | a3547a68012d879d4dfe80394eace70808722e43 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Apod_(Apod)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.16e-03 | 134 | 17 | 2 | d065449ca3679e4818b74fb7302cc7f1ce62f691 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Col3a1_(Mural.Rgs5Acta2.Col3a1)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.16e-03 | 134 | 17 | 2 | 9458e2d0dbc18d9025b66b59f3ecc2fbc5384940 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Apod_(Apod)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.16e-03 | 134 | 17 | 2 | 0be389f416818a22e80098dd809fdf45b14171e8 | |
| ToppCell | TCGA-Brain-Recurrent_Tumor-Glioblastoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.23e-03 | 138 | 17 | 2 | 142e4692d7f97ce157ed70fcb2e4a63febfbb6e4 | |
| ToppCell | TCGA-Brain-Recurrent_Tumor-Glioblastoma-Primary_GBM|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.23e-03 | 138 | 17 | 2 | 728e0576526c4525ba2038921425ab3e7d321ce2 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 1.25e-03 | 139 | 17 | 2 | 64c35411bbe67acb5010dadc4b0b1be0f8b17737 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-03 | 140 | 17 | 2 | e442c46979d725ec82f525a001c46d971fcade4d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.32e-03 | 143 | 17 | 2 | 8f897278f9ccc82ae35e4f30c5f930b2a3eb509d | |
| ToppCell | TCGA-Brain-Recurrent_Tumor|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.32e-03 | 143 | 17 | 2 | eeb8ce6e051e18b82b74aaf2fc23f0cb87fc96d5 | |
| ToppCell | PBMC-Severe-cDC_8|Severe / Compartment, Disease Groups and Clusters | 1.36e-03 | 145 | 17 | 2 | 23a9a4fd1934c4a38d9259105c1fdbac459575cb | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.43e-03 | 149 | 17 | 2 | 3980fa4f1986a2f164a1826ea043fb71f1d756cd | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.51e-03 | 153 | 17 | 2 | e9c6fb5c41adb6595c66c3a917fe455348279e54 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.51e-03 | 153 | 17 | 2 | b8b5ff7d2feea3e3a352fb5530e49f639fe1ff88 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.51e-03 | 153 | 17 | 2 | 2513edfae62a44e51d3556675a096723194c966c | |
| ToppCell | severe_COVID-19-MAIT|World / disease group, cell group and cell class (v2) | 1.53e-03 | 154 | 17 | 2 | 65ec7f7ef05c589903c4c9fe3849478c325fdc61 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-Pro-B|bone_marrow / Manually curated celltypes from each tissue | 1.53e-03 | 154 | 17 | 2 | 8a8c3851888ab86ca2b13ccc042cde1fef8d88f8 | |
| ToppCell | BAL-Control-cDC_12|Control / Compartment, Disease Groups and Clusters | 1.53e-03 | 154 | 17 | 2 | 0121d08cc527aed9b3e11ff62bb9012916f5c56b | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Trm_Tgd|lymph-node_spleen / Manually curated celltypes from each tissue | 1.55e-03 | 155 | 17 | 2 | b0e456c4915076e1d38282e116a6eb3230ae80dc | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-Tfh|Liver / Manually curated celltypes from each tissue | 1.57e-03 | 156 | 17 | 2 | 85bc34ff507f9a66c6e3ba7a3ffd5416d0073ccf | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-03 | 156 | 17 | 2 | 363f1b661048d25895e2b8681c82894c957b29c0 | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.57e-03 | 156 | 17 | 2 | 44ff0acdd5cc3575d6c24a1c2ba11cd9f55359d1 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Tall_Cell-1|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.57e-03 | 156 | 17 | 2 | 45a05c7a45a3ec8551818ab67f18b3b9553934c1 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-03 | 156 | 17 | 2 | d5207dbfbcfb885557ea1378dfe6a56d7102e94a | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.57e-03 | 156 | 17 | 2 | 55ba43cec9d79f309e9f633a6469cf03bb621e64 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-Pro-B|bone_marrow / Manually curated celltypes from each tissue | 1.57e-03 | 156 | 17 | 2 | b093dbba6662e4fffc8aa577587b77f64ac44b56 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_OPC-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.57e-03 | 156 | 17 | 2 | 27590a4d2b419644966f0037c67c761fc275e0aa | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-GC_B_(I)|bone_marrow / Manually curated celltypes from each tissue | 1.59e-03 | 157 | 17 | 2 | d4da4057917dda066da0f2aac2621fdaf1fb943b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.59e-03 | 157 | 17 | 2 | f147e24f2ece82e1c54750868954d09b3c461804 | |
| ToppCell | COPD-Epithelial-Aberrant_Basaloid|Epithelial / Disease state, Lineage and Cell class | 1.61e-03 | 158 | 17 | 2 | 8f66979e92f886d86cecbd26aaa0c5915c049734 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.61e-03 | 158 | 17 | 2 | e5636c0b608d68bd426a2b446ac508e4512e86a4 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.63e-03 | 159 | 17 | 2 | e6ff9d2bce62bf9ea173af80b688eeb40fa4ea4c | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-03 | 159 | 17 | 2 | 7ad3a91d29639b32f6264c91f401c14a35469ac0 | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 1.63e-03 | 159 | 17 | 2 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| Computational | Neighborhood of CDH11 | 3.38e-04 | 25 | 12 | 2 | GNF2_CDH11 | |
| Computational | Neighborhood of PTX3 | 7.05e-04 | 36 | 12 | 2 | GNF2_PTX3 | |
| Drug | BPAT-143 | 6.91e-09 | 6 | 17 | 3 | CID000146249 | |
| Drug | MTPG | 1.25e-07 | 14 | 17 | 3 | CID005311456 | |
| Drug | 351A | 3.91e-07 | 20 | 17 | 3 | CID000122144 | |
| Drug | isodesmosine | 1.86e-06 | 33 | 17 | 3 | CID000013811 | |
| Drug | Sirius red | 2.23e-06 | 35 | 17 | 3 | CID005486818 | |
| Drug | GK-101 | 2.43e-06 | 36 | 17 | 3 | CID000161853 | |
| Drug | AC1MRIIV | 3.11e-06 | 39 | 17 | 3 | CID003518584 | |
| Drug | Collagenase | 3.15e-06 | 4 | 17 | 2 | DB00048 | |
| Drug | diacetylrhein | 3.15e-06 | 4 | 17 | 2 | ctd:C025292 | |
| Drug | PD123177 | 4.19e-06 | 43 | 17 | 3 | CID000114899 | |
| Drug | NC-4 | 4.49e-06 | 44 | 17 | 3 | CID006420119 | |
| Drug | Madecassol | 5.15e-06 | 46 | 17 | 3 | CID000108062 | |
| Drug | d-indobufen | 6.63e-06 | 50 | 17 | 3 | CID000044562 | |
| Drug | ridogrel | 7.47e-06 | 52 | 17 | 3 | CID005362391 | |
| Drug | AG-H-50319 | 7.86e-06 | 6 | 17 | 2 | CID011819195 | |
| Drug | haloperidol | 7.89e-06 | 394 | 17 | 5 | CID000003559 | |
| Drug | NSC49633 | 7.91e-06 | 53 | 17 | 3 | CID000023340 | |
| Drug | desmosine | 7.91e-06 | 53 | 17 | 3 | CID000025435 | |
| Drug | trapidil | 9.87e-06 | 57 | 17 | 3 | CID000005531 | |
| Drug | foscarnet | 1.03e-05 | 190 | 17 | 4 | CID000003414 | |
| Drug | dimethylnitrosamine | 1.16e-05 | 196 | 17 | 4 | CID000006124 | |
| Drug | AC1LAKND | 1.27e-05 | 62 | 17 | 3 | CID000470146 | |
| Drug | AC1Q641C | 1.27e-05 | 62 | 17 | 3 | CID000005005 | |
| Drug | vitamin E | 1.36e-05 | 441 | 17 | 5 | CID000002116 | |
| Drug | 3,4,5-trihydroxy-N-(4-(thiazol-2-ylsulfamoyl)-phenyl)-benzamide | 1.47e-05 | 8 | 17 | 2 | ctd:C000594958 | |
| Drug | 4-aminoazobenzene | 1.54e-05 | 66 | 17 | 3 | CID000006051 | |
| Drug | BAPN | 1.92e-05 | 71 | 17 | 3 | CID000001647 | |
| Drug | malotilate | 1.92e-05 | 71 | 17 | 3 | CID000004006 | |
| Drug | L-3,4-dehydroproline | 2.08e-05 | 73 | 17 | 3 | CID000094284 | |
| Drug | A0395 | 2.26e-05 | 75 | 17 | 3 | CID009906466 | |
| Drug | AC1NMZ1B | 2.26e-05 | 75 | 17 | 3 | CID005034185 | |
| Drug | strontium ranelate | 2.44e-05 | 77 | 17 | 3 | CID006918182 | |
| Drug | 1zp8 | 2.44e-05 | 77 | 17 | 3 | CID004369521 | |
| Drug | Agronal | 2.64e-05 | 79 | 17 | 3 | CID000007511 | |
| Drug | homocystine | 2.95e-05 | 82 | 17 | 3 | CID000010010 | |
| Drug | halofuginone lactate | 3.29e-05 | 85 | 17 | 3 | CID000062891 | |
| Drug | hyaluronan | 3.68e-05 | 263 | 17 | 4 | CID000024759 | |
| Drug | 4-hydroxyproline | 4.03e-05 | 91 | 17 | 3 | CID000000825 | |
| Drug | AC1L9HPX | 4.17e-05 | 92 | 17 | 3 | CID000445279 | |
| Drug | D3273 | 4.44e-05 | 94 | 17 | 3 | CID005464587 | |
| Drug | isotetrandrine | 4.88e-05 | 97 | 17 | 3 | CID000005422 | |
| Drug | silibinin | 5.03e-05 | 285 | 17 | 4 | CID000005213 | |
| Drug | pyridinoline | 5.19e-05 | 99 | 17 | 3 | CID000105068 | |
| Drug | ascorbate-2-phosphate | 5.48e-05 | 15 | 17 | 2 | ctd:C011669 | |
| Drug | ticlopidine | 5.84e-05 | 103 | 17 | 3 | CID000005472 | |
| Drug | hydroxylysine | 6.91e-05 | 109 | 17 | 3 | CID000001029 | |
| Drug | AC1L1C2F | 7.10e-05 | 110 | 17 | 3 | CID000001711 | |
| Drug | Sudan II | 7.69e-05 | 113 | 17 | 3 | CID005354447 | |
| Drug | PPACK | 7.69e-05 | 113 | 17 | 3 | CID003036757 | |
| Drug | AC1L9732 | 7.90e-05 | 114 | 17 | 3 | CID000439300 | |
| Drug | pitavastatin | 7.90e-05 | 114 | 17 | 3 | CID005282451 | |
| Drug | Taylor's blue | 7.97e-05 | 18 | 17 | 2 | CID000123898 | |
| Drug | Tranilast sodium | 8.11e-05 | 115 | 17 | 3 | CID000005527 | |
| Drug | Selara | 1.04e-04 | 125 | 17 | 3 | CID000150310 | |
| Drug | DMSe | 1.22e-04 | 132 | 17 | 3 | CID000020796 | |
| Drug | ptaquiloside | 1.25e-04 | 133 | 17 | 3 | ctd:C043680 | |
| Drug | MeSAdo | 1.36e-04 | 137 | 17 | 3 | CID000000149 | |
| Drug | pirfenidone | 1.39e-04 | 138 | 17 | 3 | CID000040632 | |
| Drug | DL-penicillamine | 1.42e-04 | 139 | 17 | 3 | CID000004727 | |
| Drug | PCR 4099 | 1.42e-04 | 139 | 17 | 3 | CID000002806 | |
| Drug | ABT-100 | 1.43e-04 | 24 | 17 | 2 | CID006451154 | |
| Drug | candesartan cilexetil | 1.61e-04 | 145 | 17 | 3 | CID000002540 | |
| Drug | calcium phosphate | 1.75e-04 | 149 | 17 | 3 | CID000024441 | |
| Drug | aldosterone | 1.81e-04 | 397 | 17 | 4 | CID000005839 | |
| Drug | fulvic acid | 1.82e-04 | 27 | 17 | 2 | ctd:C005023 | |
| Drug | arabinosyladenine | 1.83e-04 | 762 | 17 | 5 | CID000000191 | |
| Drug | nifedipine | 2.15e-04 | 415 | 17 | 4 | CID000004485 | |
| Drug | L-lysyl-L-lysyl-L-lysine | 2.23e-04 | 162 | 17 | 3 | CID000072363 | |
| Drug | canaline | 2.25e-04 | 30 | 17 | 2 | CID000441443 | |
| Drug | 2-methoxy-N-(3-methyl-2-oxo-1,2,3,4-tetrahydroquinazolin-6-yl)benzenesulfonamide | 2.41e-04 | 31 | 17 | 2 | ctd:C577942 | |
| Drug | phenylpropionic acid | 2.44e-04 | 167 | 17 | 3 | CID000000107 | |
| Drug | Gold | 2.50e-04 | 432 | 17 | 4 | ctd:D006046 | |
| Drug | gabapentin | 2.53e-04 | 169 | 17 | 3 | CID000003446 | |
| Drug | celastrol; Up 200; 2.5uM; MCF7; HT_HG-U133A_EA | 2.62e-04 | 171 | 17 | 3 | 887_UP | |
| Drug | khellin | 2.62e-04 | 171 | 17 | 3 | CID000003828 | |
| Drug | Bt-m | 2.73e-04 | 33 | 17 | 2 | CID000005963 | |
| Drug | Cortisporin | 2.90e-04 | 177 | 17 | 3 | CID000004454 | |
| Drug | cyanogen-bromide | 2.90e-04 | 34 | 17 | 2 | CID000010476 | |
| Drug | AC1L1DD6 | 3.00e-04 | 179 | 17 | 3 | CID000002299 | |
| Drug | STOCK1N-35696; Up 200; 15uM; MCF7; HT_HG-U133A | 3.15e-04 | 182 | 17 | 3 | 6577_UP | |
| Drug | hematoxilina | 3.20e-04 | 183 | 17 | 3 | CID000010603 | |
| Drug | ELAN | 3.44e-04 | 37 | 17 | 2 | CID000009469 | |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | 3.51e-04 | 189 | 17 | 3 | CID000001413 | |
| Drug | Thioguanosine [85-31-4]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 3.57e-04 | 190 | 17 | 3 | 2619_UP | |
| Drug | Doxorubicin hydrochloride [25316-40-9]; Up 200; 6.8uM; MCF7; HT_HG-U133A | 3.62e-04 | 191 | 17 | 3 | 3291_UP | |
| Drug | Diethylstilbestrol [56-53-1]; Up 200; 15uM; MCF7; HT_HG-U133A | 3.74e-04 | 193 | 17 | 3 | 3429_UP | |
| Drug | Haloperidol [52-86-8]; Up 200; 10.6uM; PC3; HT_HG-U133A | 3.79e-04 | 194 | 17 | 3 | 4678_UP | |
| Drug | Pimozide [2062-78-4]; Up 200; 8.6uM; PC3; HT_HG-U133A | 3.79e-04 | 194 | 17 | 3 | 7132_UP | |
| Drug | Carnitine | 3.83e-04 | 39 | 17 | 2 | ctd:D002331 | |
| Drug | Dihydroergocristine mesylate [24730-10-7]; Up 200; 5.6uM; MCF7; HT_HG-U133A | 3.85e-04 | 195 | 17 | 3 | 7034_UP | |
| Drug | Betulinic acid [472-15-1]; Down 200; 8.8uM; PC3; HT_HG-U133A | 3.91e-04 | 196 | 17 | 3 | 4101_DN | |
| Drug | Pyrimethamine [58-14-0]; Up 200; 16uM; PC3; HG-U133A | 3.91e-04 | 196 | 17 | 3 | 1894_UP | |
| Drug | Proadifen hydrochloride [62-68-0]; Up 200; 10.2uM; PC3; HT_HG-U133A | 3.91e-04 | 196 | 17 | 3 | 5807_UP | |
| Drug | Harmalol hydrochloride dihydrate [6028-07-5]; Up 200; 14.6uM; PC3; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 5076_UP | |
| Drug | Nystatine [1400-61-9]; Down 200; 4.4uM; PC3; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 4223_DN | |
| Drug | Meptazinol hydrochloride [59263-76-2]; Down 200; 14.8uM; PC3; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 4188_DN | |
| Drug | Norgestrel-(-)-D [797-63-7]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 4730_UP | |
| Drug | 0198306-0000 [212631-61-3]; Down 200; 10uM; PC3; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 7069_DN | |
| Drug | L-azetidine-2-carboxylic acid | 4.03e-04 | 40 | 17 | 2 | CID000016486 | |
| Drug | Zoxazolamine [61-80-3]; Up 200; 23.8uM; MCF7; HT_HG-U133A | 4.03e-04 | 198 | 17 | 3 | 5390_UP | |
| Disease | Ehlers-Danlos Syndrome, Autosomal Dominant, Type Unspecified | 9.37e-07 | 3 | 17 | 2 | C0220679 | |
| Disease | EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 1 | 9.37e-07 | 3 | 17 | 2 | C4552122 | |
| Disease | frontal fibrosing alopecia | 2.70e-06 | 48 | 17 | 3 | EFO_0009855 | |
| Disease | Autoimmune Lymphoproliferative Syndrome Type 2B | 6.55e-06 | 7 | 17 | 2 | C1846545 | |
| Disease | Bleeding tendency | 6.55e-06 | 7 | 17 | 2 | C1458140 | |
| Disease | Ehlers-Danlos syndrome | 8.73e-06 | 8 | 17 | 2 | cv:C0013720 | |
| Disease | Blood Coagulation Disorders | 3.73e-05 | 16 | 17 | 2 | C0005779 | |
| Disease | Keloid | 1.84e-04 | 35 | 17 | 2 | C0022548 | |
| Disease | Arthritis, Adjuvant-Induced | 2.41e-04 | 40 | 17 | 2 | C0003865 | |
| Disease | Arthritis, Collagen-Induced | 2.41e-04 | 40 | 17 | 2 | C0971858 | |
| Disease | Arthritis, Experimental | 2.41e-04 | 40 | 17 | 2 | C0993582 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 4.23e-04 | 53 | 17 | 2 | C4707243 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GMQLFGGQFNFDEGT | 631 | O00555 | |
| FDTFGDGMGRYNVFN | 456 | Q14832 | |
| TFFSKANMAAAFGGF | 366 | Q99758 | |
| EAGFGADIGMEKFFN | 711 | Q6UB35 | |
| FQEFSFGGGLFDDMF | 156 | Q9UBS3 | |
| GGNFAAQMAGGFDEK | 176 | P02458 | |
| LMNFDGQVFFFGQKG | 21 | P55895 | |
| MKGGEYGFGAAFDAD | 281 | Q15124 | |
| AEFFFYALGMDGDFN | 106 | Q9Y4A0 | |
| MFNDFGEASQKFGFE | 1816 | P20908 | |
| AFFDFMGKNGGFEQS | 1706 | Q0VDD8 | |
| MDFQAKLGDGFEGFY | 166 | Q6P179 | |
| NEFLEFGSYQGNMFG | 346 | Q00013 | |
| FGSYQGNMFGTKFET | 351 | Q00013 | |
| NNFFFFDGMKGNGIV | 326 | Q9UBE0 | |
| FFDMAYQGFASGDGD | 241 | P00505 | |
| FGESMTDGFQFEYGG | 1326 | P02452 | |
| AKFFFDALGMEGDFN | 106 | Q4W5G0 |